TIAA CREF Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $9.46M | Buy |
136,413
+5,619
| +4% | +$390K | 0.01% | 1066 |
|
|
2018
Q4 | $5.69M | Sell |
130,794
-15,116
| -10% | -$657K | ﹤0.01% | 1291 |
|
|
2018
Q3 | $11.1M | Sell |
145,910
-37,288
| -20% | -$2.85M | 0.01% | 1050 |
|
|
2018
Q2 | $14.1M | Sell |
183,198
-12,661
| -6% | -$973K | 0.01% | 943 |
|
|
2018
Q1 | $9.99M | Buy |
195,859
+55,921
| +40% | +$2.85M | 0.01% | 1116 |
|
|
2017
Q4 | $6.49M | Buy |
139,938
+23,589
| +20% | +$1.09M | ﹤0.01% | 1446 |
|
|
2017
Q3 | $6.2M | Sell |
116,349
-2,354
| -2% | -$125K | ﹤0.01% | 1484 |
|
|
2017
Q2 | $7.37M | Sell |
118,703
-18,170
| -13% | -$1.13M | 0.01% | 1326 |
|
|
2017
Q1 | $9.28M | Sell |
136,873
-6,858
| -5% | -$465K | 0.01% | 1166 |
|
|
2016
Q4 | $10.1M | Sell |
143,731
-6,313
| -4% | -$444K | 0.01% | 1112 |
|
|
2016
Q3 | $10.6K | Sell |
150,044
-2,621
| -2% | -$186 | 0.01% | 1083 |
|
|
2016
Q2 | $7.47M | Sell |
152,665
-5,468
| -3% | -$267K | 0.01% | 1254 |
|
|
2016
Q1 | $10M | Sell |
158,133
-919
| -0.6% | -$58.2K | 0.01% | 1055 |
|
|
2015
Q4 | $17.8M | Buy |
159,052
+432
| +0.3% | +$48.5K | 0.01% | 797 |
|
|
2015
Q3 | $15.3M | Buy |
158,620
+86,154
| +119% | +$8.3M | 0.01% | 841 |
|
|
2015
Q2 | $7.42M | Buy |
72,466
+38,411
| +113% | +$3.93M | 0.01% | 1373 |
|
|
2015
Q1 | $2.11M | Hold |
34,055
| – | – | ﹤0.01% | 2186 |
|
|
2014
Q4 | $1.49M | Buy |
34,055
+699
| +2% | +$30.7K | ﹤0.01% | 2431 |
|
|
2014
Q3 | $1.89M | Buy |
33,356
+7,654
| +30% | +$433K | ﹤0.01% | 2255 |
|
|
2014
Q2 | $1.15M | Buy |
25,702
+1,505
| +6% | +$67.6K | ﹤0.01% | 2637 |
|
|
2014
Q1 | $1.18M | Buy |
+24,197
| New | +$1.18M | ﹤0.01% | 2549 |
|